AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33601736 — intervention group
Group type: EXPERIMENTAL
Intervention: High depression symptom severity (dichotomized)
Number of subjects: 722
Study 33601736 — intervention group
Group type: COMPARATOR
Intervention: DASS total or subscale scores
Number of subjects: 722
Study 33601736 — intervention group
Group type: COMPARATOR
Intervention: Persistence of high DASS symptom severity
Number of subjects: 722
Study 32515747 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet app-based dexterity training (TAD-MS) for 4 weeks, five times a week, 30 minutes per session.
Number of subjects: 9
Study 32515747 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet app-based dexterity training (TAD-MS)
Number of subjects: 9
Study 35052995 — intervention group
Group type: EXPERIMENTAL
Intervention: Biorepair Parodontgel Intensive (postbiotics-based)
Number of subjects: 30
Study 35052995 — intervention group
Group type: COMPARATOR
Intervention: Curasept Periodontal Gel (chlorhexidine-based)
Number of subjects: 30
Study 32001213 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled non-control doses group
Number of subjects: 0
Study 32001213 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 33469717 — intervention group
Group type: EXPERIMENTAL
Intervention: 27-gauge needle (32 mm × 0.2 mm)
Number of subjects: 212
Study 33469717 — intervention group
Group type: COMPARATOR
Intervention: 30-gauge needle (25 mm × 0.15 mm)
Number of subjects: 212
Study 32131146 — intervention group
Group type: EXPERIMENTAL
Intervention: Soap
Number of subjects: 29
Study 32131146 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 29
Study 35738633 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib (1.3 mg/m2 subcutaneously on days 1, 4, 8, and 11) and Pegylated Liposomal Doxorubicin (40 mg/m2 intravenously on day 4), every 4 weeks
Number of subjects: 23
Study 32955694 — intervention group
Group type: EXPERIMENTAL
Intervention: Gambling-MCT (Metacognitive Training)
Number of subjects: 25
Study 32960539 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal biopsy
Number of subjects: 24
Study 32960539 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal swab
Number of subjects: 24
Study 34725764 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation
Number of subjects: 54
Study 33559433 — intervention group
Group type: EXPERIMENTAL
Intervention: Shao's five-needle therapy combined with conventional western medical treatment
Number of subjects: 80
Study 33559433 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medical treatment
Number of subjects: 80
Study 32804024 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgically implanted cryopreserved human umbilical cord allograft
Number of subjects: 21
Study 35048892 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP) in a group format
Number of subjects: 243
Study 35048892 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 243
Study 34587385 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanimod (1 mg once daily)
Number of subjects: 457
Study 34587385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study 34471610 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized UI (N = 198)
Number of subjects: 397
Study 34471610 — intervention group
Group type: COMPARATOR
Intervention: Basic UI (N = 199)
Number of subjects: 397
Study 36123853 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led program intervention plus usual care
Number of subjects: 0
Study 36123853 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 34850160 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg once-daily
Number of subjects: 104
Study 34308585 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-arm assisted total knee arthroplasty (RATKA)
Number of subjects: 60
Study 34308585 — intervention group
Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty (TKA)
Number of subjects: 60
Study 34308585 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (RATKA and TKA)
Number of subjects: 60
Study 33213398 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Dashboard eHealth self-management intervention
Number of subjects: 0
Study 33213398 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 36014777 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention for childhood obesity
Number of subjects: 1176
Study 36014777 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1176
Study 32842112 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial vault remodeling surgery
Number of subjects: 20
Study 32842112 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (not specified)
Number of subjects: 20
Study 35301858 — intervention group
Group type: EXPERIMENTAL
Intervention: Best Practice Alert (BPA)
Number of subjects: 1856
Study 35301858 — intervention group
Group type: COMPARATOR
Intervention: No BPA
Number of subjects: 1856
Study 33176796 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (SE and OE groups)
Number of subjects: 60
Study 33176796 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (SE group)
Number of subjects: 60
Study 33176796 — intervention group
Group type: COMPARATOR
Intervention: Control group (SC)
Number of subjects: 60
Study 33176796 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 33892819 — intervention group
Group type: EXPERIMENTAL
Intervention: Low salicylate diet
Number of subjects: 7
Study 33892819 — intervention group
Group type: COMPARATOR
Intervention: High salicylate diet
Number of subjects: 7
Study 34158360 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobimetinib plus vemurafenib
Number of subjects: 495
Study 34158360 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus vemurafenib
Number of subjects: 495
Study 33035206 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) intervention, provided with 2 free finger-prick-based HIVST kits at enrollment and 2 to 4 kits every 3 months for 1 year, in addition to site-based HIV testing (SBHT)
Number of subjects: 230
Study 33035206 — intervention group
Group type: COMPARATOR
Intervention: Control group with access to site-based HIV testing (SBHT) only
Number of subjects: 230
Study 33035206 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) intervention
Number of subjects: 230
Study 35987996 — intervention group
Group type: COMPARATOR
Intervention: Propofol + saline (P group)
Number of subjects: 260
Study 35987996 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol + esketamine 0.05 mg/kg (PK1 group)
Number of subjects: 260
Study 35987996 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol + esketamine 0.1 mg/kg (PK2 group)
Number of subjects: 260
Study 35987996 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol + esketamine 0.2 mg/kg (PK3 group)
Number of subjects: 260
Study 35987996 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 260
Study 32204780 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions aligned with the Occupational Therapy Practice Framework: Domain and Process (3rd ed.)
Number of subjects: 35
Study 32204780 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (no specific occupational therapy intervention mentioned)
Number of subjects: 35
Study 35158065 — intervention group
Group type: EXPERIMENTAL
Intervention: Hook plate
Number of subjects: 30
Study 35158065 — intervention group
Group type: COMPARATOR
Intervention: Locking plate augmented with coracoclavicular fixation
Number of subjects: 30
Study 34455684 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS (n=41,851)
Number of subjects: 41851
Study 34455684 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS with severe hyperandrogenic profile (n=13,713)
Number of subjects: 41851
Study 34455684 — intervention group
Group type: COMPARATOR
Intervention: Women without PCOS (n=241,750)
Number of subjects: 41851
Study 35031487 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine-impregnated cloths
Number of subjects: 76815
Study 35031487 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.08% octenidine wash mitts
Number of subjects: 76815
Study 35031487 — intervention group
Group type: COMPARATOR
Intervention: Routine care (water and soap)
Number of subjects: 76815
Study 34279627 — intervention group
Group type: EXPERIMENTAL
Intervention: PVAC Gold
Number of subjects: 208
Study 34279627 — intervention group
Group type: COMPARATOR
Intervention: ST-CF
Number of subjects: 208
Study 33172557 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-peptide enteral nutrition formula
Number of subjects: 68
Study 33172557 — intervention group
Group type: COMPARATOR
Intervention: Intact-protein enteral nutrition formula
Number of subjects: 68
Study 34128698 — intervention group
Group type: EXPERIMENTAL
Intervention: Training program with different tones
Number of subjects: 63
Study 34128698 — intervention group
Group type: EXPERIMENTAL
Intervention: Training program with the same tone preceding target words
Number of subjects: 63
Study 34128698 — intervention group
Group type: COMPARATOR
Intervention: Cantonese native speakers (reference group)
Number of subjects: 63
Study 32350785 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 units of FFP administered before separation from CPB and 4 units of FFP and 20 units of platelet concentrate administered after separation from CPB
Number of subjects: 30
Study 32350785 — intervention group
Group type: COMPARATOR
Intervention: 8 units of FFP and 20 units of platelet concentrate administered after separation from CPB
Number of subjects: 30
Study 33780264 — intervention group
Group type: EXPERIMENTAL
Intervention: Icotinib combined with concurrent chemoradiotherapy (CRT)
Number of subjects: 29
Study 33963801 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in LI-RADS
Number of subjects: 61
Study 36216952 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with blood flow restriction (RTBFR), 30% intensity, 36 sessions over 12 weeks
Number of subjects: 14
Study 36216952 — intervention group
Group type: COMPARATOR
Intervention: Traditional resistance training (TRT), 80% intensity, 36 sessions over 12 weeks
Number of subjects: 14
Study 34487664 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 122
Study 34487664 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 122
Study 32960160 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-periodized training (NG)
Number of subjects: 35
Study 32960160 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear periodization training (PG)
Number of subjects: 35
Study 32960160 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 35
Study 32448972 — intervention group
Group type: EXPERIMENTAL
Intervention: Shockpulse
Number of subjects: 119
Study 32448972 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic lithoclast
Number of subjects: 119
Study 32532550 — intervention group
Group type: EXPERIMENTAL
Intervention: Right stellate ganglion block with 4mL of 0.2% ropivacaine under ultrasound guidance
Number of subjects: 200
Study 32532550 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stellate ganglion block)
Number of subjects: 200
Study 36446221 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Balance@ exercises and Interactive Metronome@ training (BB/IM)
Number of subjects: 16
Study 36446221 — intervention group
Group type: COMPARATOR
Intervention: Control group (typically developing children)
Number of subjects: 16
Study 34649850 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer‐driven intervention for resuming CPAP use after discontinuation.
Number of subjects: 208
Study 34649850 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer‐driven intervention for adherence to CPAP.
Number of subjects: 208
Study 34649850 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer‐driven intervention for patient satisfaction.
Number of subjects: 208
Study 34649850 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer‐driven intervention for feasibility and execution.
Number of subjects: 208
Study 34649850 — intervention group
Group type: COMPARATOR
Intervention: Control group (no peer‐driven intervention).
Number of subjects: 208
Study 33830437 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (target dose 1000 mg bid)
Number of subjects: 54
Study 33830437 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle counseling (Control)
Number of subjects: 54
Study 32268991 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal compound (500 mg of Plantago ovata husk in 30 mL water plus three drops of vinegar per dose, used as a mouthwash)
Number of subjects: 28
Study 32268991 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 28
Study 32193071 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior Simulation Suit Programme (SSSP)
Number of subjects: 139
Study 32193071 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo clothing)
Number of subjects: 139
Study 34897958 — intervention group
Group type: EXPERIMENTAL
Intervention: Variolink Esthetic LC
Number of subjects: 126
Study 34897958 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS Empress Direct with ultrasonic vibration
Number of subjects: 126
Study 34897958 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonically vibrated Estelite Omega groups
Number of subjects: 126
Study 34897958 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS Empress Direct preheated and ultrasonically vibrated
Number of subjects: 126
Study 34897958 — intervention group
Group type: COMPARATOR
Intervention: Composite resins (Estelite Omega)
Number of subjects: 126
Study 32830913 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel drug-coated balloon (DCB)
Number of subjects: 431
Study 32830913 — intervention group
Group type: COMPARATOR
Intervention: Standard percutaneous transluminal angioplasty (PTA)
Number of subjects: 431
Study 35006255 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Vascular Care
Number of subjects: 0
Study 35006255 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 0
Study 34096450 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear appeal message
Number of subjects: 378
Study 34096450 — intervention group
Group type: EXPERIMENTAL
Intervention: Social norms message
Number of subjects: 378
Study 35146797 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegoprazan 50 mg
Number of subjects: 16
Study 35146797 — intervention group
Group type: COMPARATOR
Intervention: Vonoprazan 20 mg
Number of subjects: 16
Study 35146797 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole 40 mg
Number of subjects: 16
Study 33290394 — intervention group
Group type: EXPERIMENTAL
Intervention: RV144 vaccination
Number of subjects: 100
Study 33290394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 34011436 — intervention group
Group type: EXPERIMENTAL
Intervention: P2Y12 inhibitor monotherapy after 3-month DAPT
Number of subjects: 4453
Study 34011436 — intervention group
Group type: COMPARATOR
Intervention: Conventional dual antiplatelet therapy (DAPT)
Number of subjects: 4453
Study 34011436 — intervention group
Group type: COMPARATOR
Intervention: Aspirin monotherapy after 6-month DAPT
Number of subjects: 4453
Study 33239950 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-M (CHO-electrolyte solution + MBI)
Number of subjects: 14
Study 33239950 — intervention group
Group type: COMPARATOR
Intervention: Control (noncarbohydrate solution + traveling introduction audio)
Number of subjects: 14
Study 33239950 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO (Carbohydrate-electrolyte solution + traveling introduction audio)
Number of subjects: 14
Study 34755312 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted ERAS group
Number of subjects: 120
Study 34755312 — intervention group
Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 120
Study 34303314 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip-focused neuromuscular exercise
Number of subjects: 44
Study 34303314 — intervention group
Group type: COMPARATOR
Intervention: Sham exercise
Number of subjects: 44
Study 35304299 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed incision negative pressure therapy (ciNPT) dressing for 7 days
Number of subjects: 120
Study 35304299 — intervention group
Group type: COMPARATOR
Intervention: Occlusive dressing (control) for 7 days
Number of subjects: 120
Study 33284113 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus axitinib
Number of subjects: 861
Study 33284113 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 861
Study 33413353 — intervention group
Group type: EXPERIMENTAL
Intervention: VHA healthcare providers
Number of subjects: 366
Study 33413353 — intervention group
Group type: EXPERIMENTAL
Intervention: VHA smoking cessation medication use
Number of subjects: 366
Study 33413353 — intervention group
Group type: EXPERIMENTAL
Intervention: VHA referral to smoking cessation services
Number of subjects: 366
Study 32284049 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured OA care model (physiotherapist-led education program and individually tailored exercises for 8-12 weeks)
Number of subjects: 393
Study 32284049 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured OA care model (exercise completers)
Number of subjects: 393
Study 32284049 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured OA care model (exercise non-completers)
Number of subjects: 393
Study 32284049 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 393
Study 35382960 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication disposal pouch
Number of subjects: 221
Study 35382960 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 221
Study 33862313 — intervention group
Group type: EXPERIMENTAL
Intervention: Sativex (Nabiximols)
Number of subjects: 32
Study 33862313 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 35315909 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy for 6 weeks
Number of subjects: 178
Study 35315909 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy for 3 months
Number of subjects: 178
Study 33561507 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy (RT quality graded as per protocol - PP)
Number of subjects: 442
Study 33561507 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy (RT quality graded as minor deviation - MiD)
Number of subjects: 442
Study 33561507 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy (RT quality graded as major deviation - MaD)
Number of subjects: 442
Study 35332795 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 60
Study 35332795 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy Milk Consumption (SMC)
Number of subjects: 60
Study 35332795 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training + Soy Milk (RSM)
Number of subjects: 60
Study 35332795 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 60
Study 32293527 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimised vancomycin regimen (loading dose of 25 mg/kg followed by 15 mg/kg q12h or q8h for 5 ± 1 days)
Number of subjects: 300
Study 32293527 — intervention group
Group type: COMPARATOR
Intervention: Standard vancomycin regimen (15 mg/kg q24h, q12h or q8h for 10 ± 2 days)
Number of subjects: 300
Study 32293527 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimised vancomycin regimen
Number of subjects: 300
Study 32293527 — intervention group
Group type: COMPARATOR
Intervention: Standard vancomycin regimen
Number of subjects: 300
Study 35332812 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 16
Study 35332812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 33213420 — intervention group
Group type: EXPERIMENTAL
Intervention: Stagnant water body near a house
Number of subjects: 63
Study 33213420 — intervention group
Group type: EXPERIMENTAL
Intervention: Engaging in outdoor activities before dawn or after dusk
Number of subjects: 63
Study 33213420 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a house with open eaves
Number of subjects: 63
Study 33213420 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing long-sleeved clothes when outdoors at night
Number of subjects: 63
Study 35279948 — intervention group
Group type: EXPERIMENTAL
Intervention: HARD (Restylane Defyne with lidocaine)
Number of subjects: 173
Study 35279948 — intervention group
Group type: COMPARATOR
Intervention: HAR (Restylane)
Number of subjects: 173
Study 35279948 — intervention group
Group type: EXPERIMENTAL
Intervention: HARD
Number of subjects: 173
Study 35279948 — intervention group
Group type: EXPERIMENTAL
Intervention: HARD and HAR
Number of subjects: 173
Study 32423943 — intervention group
Group type: EXPERIMENTAL
Intervention: Child survivors of PICU
Number of subjects: 300
Study 32423943 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents of child survivors
Number of subjects: 300
Study 32423943 — intervention group
Group type: EXPERIMENTAL
Intervention: Siblings of child survivors
Number of subjects: 300
Study 32423943 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative interviews with families
Number of subjects: 300
Study 34215454 — intervention group
Group type: EXPERIMENTAL
Intervention: GBS-NN vaccine (100 µg adjuvanted)
Number of subjects: 240
Study 34215454 — intervention group
Group type: EXPERIMENTAL
Intervention: GBS-NN vaccine (two doses of 50 µg adjuvanted)
Number of subjects: 240
Study 34215454 — intervention group
Group type: EXPERIMENTAL
Intervention: GBS-NN vaccine (adjuvanted)
Number of subjects: 240
Study 34215454 — intervention group
Group type: EXPERIMENTAL
Intervention: GBS-NN vaccine (two doses of 50 µg)
Number of subjects: 240
Study 32349638 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic injection
Number of subjects: 46
Study 32349638 — intervention group
Group type: COMPARATOR
Intervention: Control (no injection)
Number of subjects: 46
Study 36163490 — intervention group
Group type: EXPERIMENTAL
Intervention: Early lens extraction surgery
Number of subjects: 12
Study 36163490 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 12